These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 272843)

  • 61. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid.
    Patscheke H
    Biochem Pharmacol; 1985 Apr; 34(8):1151-6. PubMed ID: 3922373
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
    Szczeklik A; Gryglewski RJ; Musiał J; Grodzínska L; Serwónska M; Wójcik-Switek L; Marcinkiewicz E
    Acta Biol Med Ger; 1978; 37(5-6):741-2. PubMed ID: 742286
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
    Johnson GJ; Dunlop PC; Leis LA; From AH
    Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
    Hanasaki K; Arita H
    Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of various agents on prostaglandin biosynthesis and the anti-aggregatory effect.
    Förster W
    Acta Med Scand Suppl; 1980; 642():35-46. PubMed ID: 6779506
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The arachidonic acid metabolites (prostaglandins, thromboxanes, prostacyclin, leucotrienes):basics and clinical implications (author's transl)].
    Oelz O
    Ther Umsch; 1979 Oct; 36(10):882-8. PubMed ID: 119331
    [No Abstract]   [Full Text] [Related]  

  • 68. Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction.
    Smith JB; Ingerman C; Kocsis JJ; Silver MJ
    J Clin Invest; 1974 May; 53(5):1468-72. PubMed ID: 4825236
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
    Le Breton GC; Venton DL; Enke SE; Halushka PV
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4097-101. PubMed ID: 291066
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery.
    Salzman PM; Salmon JA; Moncada S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):240-7. PubMed ID: 7005425
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The regulation of prostaglandin biosynthesis: negative feedback mechanisms and the selective control of formation of I and 2 series prostaglandins: relevance to inflammation and immunity.
    Horrobin DF
    Med Hypotheses; 1980 Jul; 6(7):687-709. PubMed ID: 7402143
    [No Abstract]   [Full Text] [Related]  

  • 72. [Biosynthesis of prostaglandins and thromboxane in the blood platelets].
    Katori M
    Nihon Rinsho; 1978 Dec; 36(12):3805-12. PubMed ID: 372618
    [No Abstract]   [Full Text] [Related]  

  • 73. The role of platelet prostanoids and dense granule compounds in initial attachment, spreading and aggregation of platelets on collagen substrates.
    Leytin VL; Misselwitz F; Lyubimova EV; Domogatsky SP
    Thromb Res; 1989 Aug; 55(4):395-406. PubMed ID: 2814935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparison of the inhibitory effects of melatonin and indomethacin on platelet aggregation and thromboxane release.
    Leach CM; Thorburn GD
    Prostaglandins; 1980 Jul; 20(1):51-6. PubMed ID: 7403573
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of insulin or tolbutamide treatment on 14C-arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas, and platelets of streptozotocin-induced diabetic rats.
    Valentovic MA; Lubawy WC
    Diabetes; 1983 Sep; 32(9):846-51. PubMed ID: 6354792
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prostacyclin and thromboxane A2 release in isolated rat lungs.
    Korbut R; Boyd J; Eling T
    Prostaglandins; 1982 Jan; 23(1):67-75. PubMed ID: 7038777
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V; De Gaetano G
    Eur J Pharmacol; 1982 Dec; 85(3-4):331-3. PubMed ID: 6295787
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Involvement of platelet-derived 5-hydroxytryptamine in thromboxane A2-induced aggregation in cat platelets.
    Ogawa T; Sugidachi A; Asai F; Koike H
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):233-40. PubMed ID: 9663705
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A comparative study on the effect of cis (oleic, linoleic) and trans (elaidic, linoelaidic) fatty acids on the in vitro prostaglandin biosynthesis in human blood platelets from (1-14C) arachidonic acid.
    Srivastava KC; Awasthi KK
    Prostaglandins Leukot Med; 1982 Dec; 9(6):669-84. PubMed ID: 6818563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.